Lifestance Net Working Capital from 2010 to 2026
| LFST Stock | USD 6.91 -0.02 -0.29% |
Net Working Capital | First Reported 2020-12-31 | Previous Quarter 131.8 M | Current Value 164.2 M | Quarterly Volatility 68.9 M |
Lifestance | Net Working Capital | Build AI portfolio with Lifestance Stock |
Latest Lifestance Health's Net Working Capital Growth Pattern
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Lifestance Net Working Capital Regression Statistics
| Arithmetic Mean | 22,041,229 | |
| Geometric Mean | 32,175,172 | |
| Coefficient Of Variation | 338.91 | |
| Mean Deviation | 60,931,120 | |
| Median | -27,582,000 | |
| Standard Deviation | 74,700,451 | |
| Sample Variance | 5580.2T | |
| Range | 200M | |
| R-Value | 0.79 | |
| Mean Square Error | 2203.8T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 11,739,184 | |
| Total Sum of Squares | 89282.5T |
Lifestance Net Working Capital History
Lifestance Health Net Worth Estimate
Methodology
Unless otherwise specified, financial data for Lifestance Health Group is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Lifestance (USA Stocks:LFST) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Our reporting uses public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Normalization procedures may introduce minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Lifestance Health Group is covered by 10 analysts. 5 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, Jefferies, among others. Updates may occur throughout the day.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lifestance Stock Analysis
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |